Projects per year
Fingerprint
Dive into the research topics where Pediatrics Nephrology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Helen Bergado Lovell, MD
- Pediatrics Nephrology - Associate Professor
- Child Health Research Institute - Member
Person: Member, Academic
-
Teri J Mauch, MD, PhD
- Pediatrics Nephrology - Professor
- Children's Physicians - Children's Specialty Physicians
- Child Health Research Institute - Member
- Center for Heart and Vascular Research - Member
Person: Member, Academic, Clinician
-
A review of renal tubular acidosis
Kunchur, M. G., Mauch, T. J., Parkanzky, M. & Rahilly, L. J., Jul 1 2024, In: Journal of Veterinary Emergency and Critical Care. 34, 4, p. 325-355 31 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
Dixon, B. P., Kavanagh, D., Aris, A. D. M., Adams, B., Kang, H. G., Wang, E., Garlo, K., Ogawa, M., Amancha, P., Chakravarty, S., Heyne, N., Kim, S. H., Cataland, S., Yoon, S. S., Miyakawa, Y., Luque, Y., Muff-Luett, M., Tanaka, K. & Greenbaum, L. A., Aug 2024, In: Kidney Medicine. 6, 8, 100855.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Corrigendum to “The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2021;100:225–237 (Kidney International (2021) 100(1) (225–237), (S0085253820314186), (10.1016/j.kint.2020.10.046))
312 Study Group, Jul 2023, In: Kidney International. 104, 1, p. 205 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access